Journal
CANCER LETTERS
Volume 369, Issue 2, Pages 376-385Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2015.08.029
Keywords
Gastric cancer; miR-100; Metastasis; ZBTB7A; C/EBP alpha
Categories
Funding
- National Natural Science Foundation of China [81372856, 81172351]
- Program for New Century Excellent Talents in University [NCET-12-0335]
Ask authors/readers for more resources
MicroRNAs have been reported to play key roles in various human cancers, including gastric cancer. However, understanding of the expression of miR-100 and its regulatory mechanisms in human gastric cancer remains elusive. In this study, we reveal that miR-100 is downregulated in gastric cancer samples and gastric cancer cell lines. Furthermore, lower miR-100 expression was found in primary gastric cancer samples with lymphatic metastasis compared to those without lymphatic metastasis. Overexpression of miR-100 suppressed tumor growth in vivo and inhibited gastric cancer invasion and metastasis in vitro and in vivo. Furthermore, we demonstrated that miR-100 reduced gastric cancer aggressiveness by directly targeting ZBTB7A. Knockdown of ZBTB7A by siRNA disrupted gastric cancer progression by impairing tumor invasion and metastasis. High expression of ZBTB7A was significantly correlated with poorer prognosis in gastric cancer patients. Our results also showed that the transcription factor CCAAT/enhancer-binding protein alpha (C/EBP alpha) could induce the expression of miR-100 by binding to the putative promoter region of miR-100. This study demonstrated that miR-100 could be induced by C/EBPa and may act as a tumor suppressor gene by inhibiting ZBTB7A. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available